Novel Site-Specific Fatty Chain-Modified GLP-1 Receptor Agonist with Potent Antidiabetic Effects

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Xia ZhongZhi Chen

Abstract

Glucagon-like peptide-1 receptor (GLP-1R) agonists have emerged as treatment options for type 2 diabetes mellitus (T2DM). Here, we designed a high-throughput GLP-1R extracellular domain (ECD)-based system that enabled the screening of high-potency receptor-biased GLP-1R agonists demonstrating new pharmacological virtues. Firstly, six 12-mer peptides (termed PEP01⁻06), screened from a large phage displayed peptide library were fused to the N-terminus of Exendin-4 (29⁻39) to generate PEP07⁻12. By the use of four lysine-altered PEP07 (PEP13⁻16) as the starting point, a series of fatty chain conjugates (PEP17⁻20) were synthesized and evaluated by in vitro GLP-1R-based cell assays. In addition, the acute and long-term in vivo effects on diet-induced obesity (DIO) mice were further evaluated. All four conjugates showed good receptor activation efficacy, and PEP20 was selected to undergo further assessment. Preclinical experiments in DIO mice demonstrated that PEP20 had significant insulinotropic activities and glucose-lowering abilities. Moreover, a prolonged antidiabetic effect of PEP20 was also observed by the hypoglycemic test in DIO mice. Furthermore, long-term treatment with PEP20 achieved beneficial effects on the food intake, ...Continue Reading

References

Nov 5, 1999·Biochimica Et Biophysica Acta·D R Flower
Oct 3, 2002·Nature Reviews. Drug Discovery·Susan R GeorgeSamuel P Lee
Jan 19, 2005·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·B Ahrén, O Schmitz
Mar 11, 2005·Diabetes/metabolism Research and Reviews·Juris J Meier, Michael A Nauck
Aug 24, 2007·Proceedings of the National Academy of Sciences of the United States of America·Christoph ParthierMilton T Stubbs
Feb 22, 2008·The Journal of Biological Chemistry·Steffen RungeRainer Rudolph
Oct 29, 2009·The Journal of Biological Chemistry·Christina Rye UnderwoodSteffen Reedtz-Runge
Jan 9, 2010·Cleveland Clinic Journal of Medicine·Jaime A Davidson
May 1, 2010·Nature Reviews. Drug Discovery·Sudarshan RajagopalRobert J Lefkowitz
Nov 26, 2010·Vitamins and Hormones·Christina Rye UnderwoodSteffen Reedtz-Runge
Jan 20, 2011·British Journal of Pharmacology·Nian GongYong-Xiang Wang
Mar 28, 2012·Protein Expression and Purification·Elodie MaîtrepierreLoïc Briand
Jun 5, 2012·Pharmacology & Therapeutics·Young Min ChoTimothy J Kieffer
Jun 6, 2012·Experimental Diabetes Research·Francis S Willard, Kyle W Sloop
Aug 1, 2012·Diabetes Technology & Therapeutics·Krystal L EdwardsBrian K Irons
Sep 5, 2012·Nature Reviews. Endocrinology·Juris J Meier
Jul 19, 2013·Nature·Fai Yiu SiuRaymond C Stevens
Oct 24, 2014·Cardiovascular Diabetology·Francisco Kerr Saraiva, Andrei C Sposito
Dec 4, 2014·Cardiovascular & Hematological Agents in Medicinal Chemistry·Megan KypreosDebabrata Mukherjee
Jan 20, 2015·Annals of Internal Medicine·Naykky Singh Ospina, Victor M Montori
Feb 14, 2015·Therapeutic Advances in Endocrinology and Metabolism·Jennifer M TrujilloSamuel L Ellis
Jul 16, 2015·The Review of Diabetic Studies : RDS·Theodosios D FilippatosMoses S Elisaf
May 27, 2016·The Journal of Biological Chemistry·Li-Hua ZhaoH Eric Xu
Mar 30, 2018·European Journal of Medicinal Chemistry·Xia ZhongHongjian Li

❮ Previous
Next ❯

Methods Mentioned

BETA
phage display
six hybrid
acylation
ELISA

Software Mentioned

GraphPad
GraphPad Prism
Biacore 8K

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.